Tamai S, Sugimura H, Caporaso N E, Resau J H, Trump B F, Weston A, Harris C C
Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, MD 20892.
Int J Cancer. 1990 Sep 15;46(3):411-5. doi: 10.1002/ijc.2910460314.
The L-myc DNA-restriction fragment length polymorphism, revealed by EcoRI, has been studied in both a lung cancer case-control framework and a cohort of 40 non-diseased unrelated individuals. No association was found between the L-myc allelic frequencies and disease status, tumor stage or lung cancer histology. A strong association was, however, observed between the L-myc allelic frequencies and ethnic origin (black or white) of the subjects. Among American whites the allelic distribution at the L-myc proto-oncogene locus was almost identical to that previously reported for Japanese subjects. Among the American black population there was a significantly higher frequency of the presence of the polymorphic EcoRI restriction site in the second intron of the L-myc proto-oncogene. These data emphasize the importance of conducting epidemiologic studies that control for ethnic factors and indicate that L-myc EcoRI allelotypes do not appear to be predictive of lung cancer risk or disease status in American blacks and whites.
通过EcoRI揭示的L-myc DNA限制性片段长度多态性,已在肺癌病例对照研究框架以及40名无疾病的无关个体队列中进行了研究。未发现L-myc等位基因频率与疾病状态、肿瘤分期或肺癌组织学之间存在关联。然而,观察到L-myc等位基因频率与受试者的种族起源(黑人或白人)之间存在强烈关联。在美国白人中,L-myc原癌基因位点的等位基因分布几乎与先前报道的日本受试者相同。在美国黑人人群中,L-myc原癌基因第二个内含子中多态性EcoRI限制性位点的存在频率显著更高。这些数据强调了进行控制种族因素的流行病学研究的重要性,并表明L-myc EcoRI等位基因型似乎不能预测美国黑人和白人的肺癌风险或疾病状态。